Drugs / Atropin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04903470 | Dec 2022 → Dec 2026 expected | outlet dysfunction constipation | The California Medical Innovations Institute, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Atropin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04903470 ↗ |
| Action | Inhibit | “Atropin is an anticholinergic drug that is expected to inhibit rectal contractions and make defecation more difficult.” NCT04903470 ↗ |